Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec;50(6):1214-1215.
doi: 10.1016/j.semarthrit.2020.09.012. Epub 2020 Oct 2.

Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members

Achille Marino  1 , Micol Romano  2 , Maurizio Gattinara  2 , Rolando Cimaz  3
Affiliations
Comment

Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members

Achille Marino et al. Semin Arthritis Rheum. 2020 Dec.
No abstract available

Keywords: COVID-19; Juvenile idiopathic arthritis; Rheumatic disease; SARS-CoV-2; TNF inhibitor.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

Comment on

References

    1. Michelena X, Borrell H, López-Corbeto M, López-Lasanta M, Moreno E, Pascual-Pastor M. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Semin Arthritis Rheum. 2020;50(4):564–570. doi: 10.1016/j.semarthrit.2020.05.001. - DOI - PMC - PubMed
    1. Marino A, Giani T, Cimaz R. Risks associated with use of TNF inhibitors in children with rheumatic diseases. Expert Rev Clin Immunol. 2019;15(2):189–198. doi: 10.1080/1744666X.2019.1550359. - DOI - PubMed
    1. Landewé RB, Machado PM, Kroon F, Bijlsma HW, Burmester GR, Carmona L. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis. 2020;79(7):851–858. doi: 10.1136/annrheumdis-2020-217877. - DOI - PubMed
    1. Wahezi DM, Lo MS, Rubinstein TB, Ringold S, Ardoin SP, Downes KJ. American College of Rheumatology Guidance for the Management of Children with Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1. Arthritis Rheumatol. 2020 doi: 10.1002/art.41455. - DOI - PMC - PubMed
    1. Filocamo G, Minoia F, Carbogno S, Costi S, Romano M, Cimaz R. Pediatric Rheumatology Group of the Milan Area. Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs. J Rheumatol. 2020 doi: 10.3899/jrheum.200483. jrheum.200483. - DOI - PubMed

Substances